The impella recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 1, 2013, Pages

  Kovacic, Jason C ^a   Nguyen, Huy T ^a   Karajgikar, Rucha ^a   Sharma, Samin K ^a   Kini, Annapoorna S ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

coronary disease; left ventricular assist device; revascularization

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; ARTICLE; ASSISTED CIRCULATION; CARDIOVASCULAR SURGICAL EQUIPMENT; CATHETER; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; FEMALE; GUIDE WIRE; HEART INFARCTION; HEART INJURY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL; HUMAN; J WIRE; LEFT ATRIAL PERFORATION; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MICROCATHETER; MORTALITY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; SCORING SYSTEM; SOCIETY OF THORACIC SURGEON RISK SCORE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME; VASCULAR ACCESS;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84879421030     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22929     Document Type: Article

References (20)

1. American Heart Association. Heart Disease and Stroke Statistics-2010 Update. Available at:http://www.americanheart. org/presenter.jhtml?identifier= 1200026. Last accessed 29 January 2011.
2. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R,. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13.
3. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW,. The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-227.
4. Grayson AD, Moore RK, Jackson M, Rathore S, Sastry S, Gray TP, Schofield I, Chauhan A, Ordoubadi FF, Prendergast B, Stables RH,. Multivariate prediction of major adverse cardiac events after 9914 percutaneous coronary interventions in the north west of England. Heart 2006; 92: 658-663.
5. O'Connor GT, Malenka DJ, Quinton H, Robb JF, Kellett MA Jr, Shubrooks S, Bradley WA, Hearne MJ, Watkins MW, Wennberg DE, Hettleman B, O'Rourke DJ, McGrath PD, Ryan T Jr, VerLee P,. Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994-1996. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 1999; 34: 681-691.
6. Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den Brand MJ, Colombo A, Morice MC, Dawkins K, de Bruyne B, Kornowski R, de Servi S, Guagliumi G, Jukema JW, Mohr FW, Kappetein AP, Wittebols K, Stoll HP, Boersma E, Parrinello G,. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 2007; 99: 1072-1081.
7. Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C,. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2009; 2: 302-308.
8. Briguori C, Airoldi F, Chieffo A, Montorfano M, Carlino M, Sangiorgi GM, Morici N, Michev I, Iakovou I, Biondi-Zoccai G, Colombo A,. Elective versus provisional intraaortic balloon pumping in unprotected left main stenting. Am Heart J 2006; 152: 565-572.
9. Mishra S, Chu WW, Torguson R, Wolfram R, Deible R, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R,. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol 2006; 98: 608-612.
10. Remmelink M, Sjauw KD, Henriques JP, de Winter RJ, Koch KT, van der Schaaf RJ, Vis MM, Tijssen JG, Piek JJ, Baan J Jr,. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics. Catheter Cardiovasc Interv 2007; 70: 532-537.
11. Valgimigli M, Steendijk P, Sianos G, Onderwater E, Serruys PW,. Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention. Catheter Cardiovasc Interv 2005; 65: 263-267.
12. Vranckx P, Schultz CJ, Valgimigli M, Eindhoven JA, Kappetein AP, Regar ES, Van Domburg R, Serruys PW,. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG. Catheter Cardiovasc Interv 2009; 74: 302-310.
13. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW,. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006; 152: 469 e1-e8.
14. Rajdev S, Krishnan P, Irani A, Kim MC, Moreno PR, Sharma SK, Kini AS,. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: Single-center experience. J Invasive Cardiol 2008; 20: 67-72.
15. Dixon SR, Henriques JP, Mauri L, Sjauw K, Civitello A, Kar B, Loyalka P, Resnic FS, Teirstein P, Makkar R, Palacios IF, Collins M, Moses J, Benali K, O'Neill WW,. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): Initial U.S. experience. JACC Cardiovasc Interv 2009; 2: 91-96.
16. Henriques JP, Remmelink M, Baan J Jr, van der Schaaf RJ, Vis MM, Koch KT, Scholten EW, de Mol BA, Tijssen JG, Piek JJ, de Winter RJ,. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol 2006; 97: 990-992.
17. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G,. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005; 26: 1276-1283.
18. Vranckx P, Meliga E, De Jaegere PP, Van den Ent M, Regar ES, Serruys PW,. The TandemHeart, percutaneous transseptal left ventricular assist device: A safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience. EuroIntervention 2008; 4: 331-337.
19. Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, de Belder A, Redwood S,. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention. JAMA 2010; 304: 867-874.
20. Sjauw KD, Konorza T, Erbel R, Danna PL, Viecca M, Minden HH, Butter C, Engstrom T, Hassager C, Machado FP, Pedrazzini G, Wagner DR, Schamberger R, Kerber S, Mathey DG, Schofer J, Engstrom AE, Henriques JP,. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol 2009; 54: 2430-2434.